(Q68145831)

English

Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol

scientific article published on 01 April 1992

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

G. M. Van Kempen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1599984

13 October 2022

F. G. Zitman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1599984

13 October 2022

A. C. Linssen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1599984

13 October 2022

P. M. Edelbroek

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1599984

13 October 2022

language of work or name

0 references

publication date

1 April 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0006322392902766?httpAccept=text/xml

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

https://api.elsevier.com/content/article/PII:0006322392902766?httpAccept=text/plain

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

670-680

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Pseudocholinesterase in obsessive-compulsive patients

1

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Platelet MAO in patients with idiopathic pain disorders

2

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

5-HIAA and HVA in CSF in patients with idiopathic pain disorders

3

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients

4

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Urinary phenylacetate and response to methylphenidate

5

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Biological markers for depression in chronic pain.

6

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Plasma MHPG in depression: effects of acute and chronic desipramine treatment

7

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment

8

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

A new and rapid colorimetric determination of acetylcholinesterase activity

9

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Serotonin metabolism in migraine

10

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients

11

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Platelet MAO and amitriptyline treatment

12

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

13

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Differences in serum cortisol concentrations in organic and psychogenic chronic pain syndromes.

14

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Cholinergic processes in blood samples from patients with major psychiatric disorders

16

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man

17

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Clinical use of the determination of serotonin in whole blood

18

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Plasma control in psychiatric and neurological patients with pain

20

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Serum pseudocholinesterase in psychiatric patients

21

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Time course of schizophrenia and platelet 5-HT level

22

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

MONOAMINE OXIDASE ACTIVITY AND AFFECTIVE ILLNESS

23

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls

24

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Assay of phenol sulphotransferase in human blood

25

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Effects of tricyclic antidepressants on platelet monoamine oxidase activity

27

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Urinary phenyl acetate: a diagnostic test for depression?

28

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Determination of free and total 3-methoxy-4-hydroxyphenylethylene glycol in human plasma by high-performance liquid chromatography with electrochemical detection

30

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Cholinesterases in primary affective disorders

33

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Assay of platelet monoamine oxidase in whole blood

34

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients

36

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin

37

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Personality traits in patients with idiopathic pain disorder.

38

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Urinary 3-methoxy-4-hydroxyphenethylene glycol in the prediction of pain and depression relief with doxepin: preliminary findings.

39

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?

40

1 reference

10.1016/0006-3223(92)90276-6

https://api.crossref.org/works/10.1016/0006-3223(92)90276-6

13 October 2022

Identifiers

10.1016/0006-3223(92)90276-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1599984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68145831&oldid=1749798902"